Treatment Set TS349575 49288-0916-3 Shape Pill Image | Pharmaguru.com

Home > National Drug Code (NDC) > Treatment Set TS349575

Treatment Set TS349575 - 49288-0916-3 - (Treatment Set TS349575)

Alphabetical Index

0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Drug Information Labeler Information Package Information NDC Record

Drug Information of Treatment Set TS349575

Product NDC:	49288-0916
Proprietary Name:	Treatment Set TS349575
Non Proprietary Name:	Treatment Set TS349575
Active Ingredient(s):	.0004; .005; .00008; .005; .005; .002; 400; 1000; 400; .002; 160 g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; [BAU]/mL; [AU]/mL; [BAU]/mL; g/mL; [BAU]/mL & nbsp; Treatment Set TS349575
Administration Route(s):	INTRADERMAL; SUBCUTANEOUS
Dosage Form(s):	INJECTION, SOLUTION
Coding System:	National Drug Codes(NDC)

Labeler Information of Treatment Set TS349575

Product NDC:	49288-0916
Labeler Name:	Antigen Laboratories, Inc.
Product Type:	NON-STANDARDIZED ALLERGENIC
FDA Application Number:	BLA102223
Marketing Category:	BLA
Start Marketing Date:	19861031

Package Information of Treatment Set TS349575

Package NDC:	49288-0916-3
Package Description:	10 mL in 1 VIAL, MULTI-DOSE (49288-0916-3)

NDC Information of Treatment Set TS349575

NDC Code	49288-0916-3
Proprietary Name	Treatment Set TS349575
Package Description	10 mL in 1 VIAL, MULTI-DOSE (49288-0916-3)
Product NDC	49288-0916
Product Type Name	NON-STANDARDIZED ALLERGENIC
Non Proprietary Name	Treatment Set TS349575
Dosage Form Name	INJECTION, SOLUTION
Route Name	INTRADERMAL; SUBCUTANEOUS
Start Marketing Date	19861031
Marketing Category Name	BLA
Labeler Name	Antigen Laboratories, Inc.
Substance Name	ALTERNARIA ALTERNATA; ASPERGILLUS FUMIGATUS; AVENA SATIVA POLLEN; CANIS LUPUS FAMILIARIS HAIR; CLADOSPORIUM HERBARUM; COCHLIOBOLUS SATIVUS; CYNODON DACTYLON POLLEN; DERMATOPHAGOIDES PTERONYSSINUS; FELIS CATUS HAIR; PASCOPYRUM SMITHII POLLEN; PHLEUM PRATENSE POLLEN
Strength Number	.0004; .005; .00008; .005; .005; .002; 400; 1000; 400; .002; 160
Strength Unit	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; [BAU]/mL; [AU]/mL; [BAU]/mL; g/mL; [BAU]/mL
Pharmaceutical Classes	Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Animal Hair Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Dander [Chemical/Ingredient],Allergens [Chemical/Ingredient],Salivary Proteins and Peptides [Chemical/Ingredient],Non-Standardized Animal Hair Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fur [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Insect Protein Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Antigens, Dermatophagoides [Chemical/Ingredient],Insect Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient]

Complete Information of Treatment Set TS349575

Featured Tools

NDC Directory

Pill Identifier

Latest Updates

FDA Consumer Updates Drug Recalls Medwatch Safety Alerts

General Information

Medical Words Medical Acronyms